Results 131 to 140 of about 8,952 (190)
Real-World Cutaneous Immune-Related Adverse Events of Immunotherapy in Melanoma: A Systematic Review and Meta-Analysis. [PDF]
Zarańska K +4 more
europepmc +1 more source
Autoimmunity to Collagen XVII (BP180-Ag2) in Pemphigoid Associated With Parkinson's Disease. [PDF]
Cid-Puente R +5 more
europepmc +1 more source
Omalizumab in the management of bullous pemphigoid: a six-month retrospective study. [PDF]
Ürün M, Yılmaz ÇE, Ürün YG.
europepmc +1 more source
Bullous Diseases in the Perioperative Setting: Anesthetic Considerations. [PDF]
Bokaee SA, Patel A.
europepmc +1 more source
Ramipril-Induced Annular Bullous Pemphigoid: A Clinical Mimic of Linear IgA Dermatosis. [PDF]
Karaca Ural Z.
europepmc +1 more source
Early-onset gestational pemphigoid in the first trimester: a diagnostic pitfall. [PDF]
Di Lorito A +4 more
europepmc +1 more source
Dupilumab treatment outcomes in bullous pemphigoid: a systematic review and single-arm meta-analysis. [PDF]
Chen Y, Sun K, Chang J.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
European Journal of Dermatology, 2022
Bullous pemphigoid (BP) is relatively rare in the paediatric age group, with slightly more than 100 cases of BP reported in the literature. In this article, we focus on infantile BP (>= 28 days, <12 months), presenting a systematic review of cases of infantile BP in the literature from 1977 up to the present day. Fifty-four articles were selected,
Cozzani, Emanuele +4 more
openaire +2 more sources
Bullous pemphigoid (BP) is relatively rare in the paediatric age group, with slightly more than 100 cases of BP reported in the literature. In this article, we focus on infantile BP (>= 28 days, <12 months), presenting a systematic review of cases of infantile BP in the literature from 1977 up to the present day. Fifty-four articles were selected,
Cozzani, Emanuele +4 more
openaire +2 more sources

